Literature DB >> 23411904

Multiply recurrent solitary fibrous tumor of the orbit without malignant degeneration: a 45-year clinicopathologic case study.

Gregory J Griepentrog1, Gerald J Harris, Eduardo V Zambrano.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23411904     DOI: 10.1001/2013.jamaophthalmol.69

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


× No keyword cloud information.
  6 in total

1.  Orbit Solitary Fibrous Tumor: A Proposed Risk Prediction Model Based on a Case Series and Comprehensive Literature Review.

Authors:  Lester D R Thompson; Sofia S Liou; Kenneth A Feldman
Journal:  Head Neck Pathol       Date:  2020-06-11

2.  Recurrent Orbital Solitary Fibrous Tumor in a 12-Year-Old.

Authors:  Alexander F Vu; Rao V Chundury; Alexander D Blandford; Julian D Perry
Journal:  Ocul Oncol Pathol       Date:  2016-10-29

Review 3.  Ocular adnexal (orbital) solitary fibrous tumor: nuclear STAT6 expression and literature review.

Authors:  Aleksandra Petrovic; Aurélie Obéric; Alexandre Moulin; Mehrad Hamedani
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-03-13       Impact factor: 3.117

4.  Solitary Fibrous Tumor of the Orbit: A Case Series With Clinicopathologic Correlation and Evaluation of STAT6 as a Diagnostic Marker.

Authors:  Nathan W Blessing; J Antonio Bermudez-Magner; Maria P Fernandez; Andrew E Rosenberg; Sander R Dubovy; Thomas E Johnson
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2020 Mar/Apr       Impact factor: 2.011

5.  Malignant solitary fibrous tumor of the orbit: Spectrum of histologic features.

Authors:  Lilangi S Ediriwickrema; Michael Burnstine; Maria S Saber; Narsing Rao
Journal:  Am J Ophthalmol Case Rep       Date:  2016-10-28

6.  Orbital solitary fibrous tumor: a clinicopathologic study from a Chinese tertiary hospital with a literature review.

Authors:  Jianqin Shen; Huiyan Li; Shi Feng; Hongguang Cui
Journal:  Cancer Manag Res       Date:  2018-05-09       Impact factor: 3.989

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.